Navigation Links
Breakthrough in organ rejection diagnosis examines gene behavior
Date:11/19/2007

Edmonton, Canada November 19, 2007 - A new article appearing in American Journal of Transplantation describes a revolutionary technique for more clearly identifying the possibility of organ rejection in kidney transplants. The technique, which uses a microarray or Gene Chip, a process of examining DNA sequences, defines how major causes of organ disease leading to rejection share similar disturbances in gene behavior. The study is the first to show how gene sets, as opposed to single genes, can be used for diagnosis of rejection in individual patients, and offers new insight into the mechanisms of these gene changes.

The key problem in transplantation is to diagnose rejection. This has traditionally been done with the microscope by reading the appearance of the tissue. We are showing how this can be performed by reading the changes in expression of genes, and in particular, expression of sets of genes, says Philip F. Halloran, M.D., lead author of the study and Editor-in-Chief of American Journal of Transplantation. This is a more objective and accurate method of identifying the possibility of organ rejection.

The authors established sets of genes transcripts sets based on disease pathogenesis. They found a threshold for expression below which the studied biopsies did not show evidence of rejection. The findings displayed a series of major biologic indicators that occur before and during organ rejection. The results showed that previous histologic criteria, particularly relating to the cut-off between borderline organ acceptance and rejection, are unreliable.

The gene behaviors identified showed strong correlations, indicating that disturbances leading to transplant rejection have stereotyped structures. Samples from the study that lacked these disturbances did not lead to organ rejection.

The features of this structure are also found in lower levels in many forms of organ disease and injury. The system of reading biopsi
'/>"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
2. drugstore.com and Revolution Health Group Announce Breakthrough Deal
3. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
4. CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency
5. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
8. Pill box organizers increase HIV patients adherence and improve viral suppression
9. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
10. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
11. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... 9 Actress Mariska Hargitay and th... on Saturday to raise awareness about the need fo...lifornia by building healing and wellness kits for...ed to give one to each of the estimated 600 women ...y,s domestic violence shelters. ,, "Our goal is...
(Date:11/9/2009)...0 National Ambassador ,, WHITE PLAINS, N.Y., ...f Weston, Fla., was born so early and with so many...whether he would survive -- or if he would ever wa...amed March of Dimes 2010 National Ambassador. ,...st minutes of motherhood and I was completely deva...
(Date:11/9/2009)...e-USNewswire/ -- For the third consecutive year, t...ected the most preferred hospital for cancer care ...e National Research Corporation. ,, (Logo: h...OSLOGO ) ,, The annual survey was conducted th...8 and August 2009. Survey respondents were the pri...
(Date:11/9/2009)...went from incapacitated to working again, , ...ical stimulation of a certain area of the brain ma...on, say German researchers. , They implanted el...ns of 10 people. This area of the brain is part o...ber good experiences and puts them in a state of p...
(Date:11/9/2009)...re/ -- Phoenix House , the nation,s leading n...vention program, announced today its appointment o...ally recognized leader in substance abuse treatmen...ve January 1, 2010. ,, "Dr. Deni Carise is at...esearch and her work has resulted in a significant...
Breaking Medicine News(10 mins):Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3
...Lands DentalCare Partners and Dental One Business,...s at,Zimmerman announce another win: DentalCare Pa...the dental practice management industry - who,s $1...ts and unit count., "It was time for us to make a...
... The International Society for ...nch of a YouTube channel created by the University...m cell science. The channel comes during a heighte...e to accelerate medical research and develop new s...
...w discovery by London biologists may yield new way... In a research article published in the November 2...w.fasebj.org ), the scientists confirm the two-way...newly transplanted organs should become "invisible...
...s can help decrease wait time, increase physician ...reduce overcrowding,decrease patient wait time, an...rum (NQF) endorsed 10 national voluntary consensus...igh demand,and capacity issues have increased pati...
...S, Ohio, Oct. 30 Medicare Advantage plans in 87,c... the design of their,2009 medical and Part D presc... Choice Gold Award recipients were selected from o...ch.com. According,to HealthMetrix Research Inc. pr...
...rence Call to Be Held at 4:00 P.M. Eastern Time -,...sdaq: VPHM ) will host a conference call and live...day, November 5, 2008 to discuss the,commercializa...is against angioedema attacks in adolescent and ad...
Other Medicine News:Health News:Zimmerman's Latest Win Has Everyone Smiling 2Health News:Zimmerman's Latest Win Has Everyone Smiling 3Health News:International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate Scientific Perspectives on Stem Cell Research 2Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 2Health News:NQF Endorses Measures to Address Care Coordination and Efficiency in Hospital Emergency Departments 3Health News:HealthMetrix Research Selects 2009 Medicare Advantage Plans for Best Overall Benefit Value 2Health News:HealthMetrix Research Selects 2009 Medicare Advantage Plans for Best Overall Benefit Value 3Health News:HealthMetrix Research Selects 2009 Medicare Advantage Plans for Best Overall Benefit Value 4Health News:ViroPharma to Discuss Commercialization and Launch of Cinryze(TM) on November 5, 2008 2
(Date:11/9/2009)...09 Arena Pharmaceuticals...esults for the third quarter ended September 30, 2...le to common stockholders in the third quarter of ...d to a net loss allocable to common stockholders i...0.76 per share, and a net loss allocable to common...
(Date:11/9/2009)...ov. 9 TessArae® LLC, a global...ons, announces the launch of new integrated produc...hat underlie human hereditary diseases. The combi... resequencing with novel nucleotide sequence basec...reening for all targeted mutations in multiple gen...
(Date:11/9/2009)... AMD LASERS just announced that ind..., has accepted the position of Medical Director. ... overseeing research and development of new soft a...ance for continuing education credits, authoring a...tions, and lecturing and seminar engagements. ,...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9TessArae Delivers Lower Cost Option to Genetic Testing Market 2AMD LASERS Names Dr. James Jesse as Medical Director 2Social Activity Keeps Elders Young Agile 49673 1Social Activity Keeps Elders Young Agile 49673 2Social Activity Keeps Elders Young Agile 49673 3Patients Often Not Told About Abnormal Test Results 49670 1Patients Often Not Told About Abnormal Test Results 49670 2Patients Often Not Told About Abnormal Test Results 49670 3Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 1Vermont Receives National Award for Physician e Prescribing Thanks to Efforts by Local Healthcare Firm 49668 2
...lleval,University Hospital, Oslo, Norway), lead in...rtic Stenosis (SEAS) Study, will provide an update...ent in London will be Sir Richard Peto (Professor ...ctor of the Clinical Trials Service,Unit, Universi...r of,Medicine and Epidemiology at the University o...
... at the,Nemours Center for Childhood Cancer Resear...s Biomedical Research at the Alfred I. duPont Hosp...r called prostate specific,membrane antigen (PSMA)...ith advanced prostate cancer, has a contributory r...disease. A biomarker is any biomolecule that is,as...
Other Medicine Technology:Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 3
VITOSS Synthetic Cancellous Bone Void Filler
...material composed of Tricalcium Phosphate, which i...of human bone. TCP is an osteoconductive material ...t of bone forming cells and allows for the develop...as between each granule. Conduit TCP strikes the p...
Weitlaner-Locktite retractors
Baby Weitlaner Retractor
Medicine Products: